This article is more than 5 years old. Information may no longer be current.
Alcon reports growth in 2011
Click Here to Manage Email Alerts
ATLANTA — Alcon Laboratories experienced a 10% increase in net sales for 2011 over 2010, according to a company executive at an Alcon-sponsored press conference held during SECO 2012.
Jim Murphy, Alcon vice president and general manager, reported 2011 net sales of $9.9 billion across the company's three businesses: $3.948 billion in pharmaceutical, $3.587 billion in surgical and $2.414 billion in vision care.
In Alcon's vision care business, Air Optix monthly contact lenses and Clear Care peroxide cleaning solution both grew in double digits. The company experienced the global launch of Opti-Free PureMoist, and Dailies Total 1 will launch in the U.S. in 2013, Mr. Murphy said.
In the pharmaceutical business, Systane and Systane Balance drove Alcon's dry eye portfolio, which grew 24%. Infection/inflammation product sales were up 14%, led by Nevanac (nepafenac ophthalmic suspension 0.1%) and Durezol (difluprednate ophthalmic emulsion 0.05%).
Global sales of advanced technology IOLs, part of Alcon's surgical business, grew 15%, led by Acrysof IQ Toric and Acrysof IQ Restor. Mr. Murphy said the LenSx femtosecond laser for refractive cataract surgery was launched, and more than 500 surgeons are now trained.